Pages that link to "Q27765312"

The following pages link to Solution structure of methionine-oxidized amyloid beta-peptide (1-40). Does oxidation affect conformational switching? (Q27765312):

Displaying 41 items.

• Alzheimer's disease--a panorama glimpse (Q27011749) (← links)
• Strategies for dealing with conformational sampling in structural calculations of flexible or kinked transmembrane peptides. (Q30359168) (← links)
• Sulphur Atoms from Methionines Interacting with Aromatic Residues Are Less Prone to Oxidation. (Q30381746) (← links)
• NMR studies in aqueous solution fail to identify significant conformational differences between the monomeric forms of two Alzheimer peptides with widely different plaque-competence, A beta(1-40)(ox) and A beta(1-42)(ox). (Q30666112) (← links)
• CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia (Q33239180) (← links)
• Oxidation of methionine residues in polypeptide ions via gas-phase ion/ion chemistry. (Q33610884) (← links)
• Structural Changes of Amyloid Beta in Hippocampus of Rats Exposed to Ozone: A Raman Spectroscopy Study (Q33710743) (← links)
• Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids (Q33882219) (← links)
• Alzheimer's amyloid fibrils: structure and assembly (Q33971270) (← links)
• Oligomerizaiton and fibril asssembly of the amyloid-beta protein. (Q33971276) (← links)
• Role of electrostatic interactions in amyloid beta-protein (A beta) oligomer formation: a discrete molecular dynamics study (Q35794575) (← links)
• Molecular pathways to neurodegeneration (Q35844771) (← links)
• Crystallization and preliminary X-ray diffraction analysis of the Fab fragment of WO2, an antibody specific for the Abeta peptides associated with Alzheimer's disease. (Q36646809) (← links)
• Structure-activity relationship studies of gonadotropin-releasing hormone antagonists containing S-aryl/alkyl norcysteines and their oxidized derivatives (Q36876855) (← links)
• Computational Insights into the Development of Novel Therapeutic Strategies for Alzheimer’s Disease (Q37855869) (← links)
• Structure of N-terminal sequence Asp-Ala-Glu-Phe-Arg-His-Asp-Ser of Aβ-peptide with phospholipase A2 from venom of Andaman Cobra sub-species Naja naja sagittifera at 2.0 Å resolution (Q38612518) (← links)
• Modeling the Aggregation Propensity and Toxicity of Amyloid-β Variants. (Q40506178) (← links)
• Flavones from Scutellaria baicalensis Georgi attenuate apoptosis and protein oxidation in neuronal cell lines (Q40721535) (← links)
• Similarities in the thermodynamics and kinetics of aggregation of disease-related Abeta(1-40) peptides (Q41989525) (← links)
• On the nucleation of amyloid beta-protein monomer folding (Q42215600) (← links)
• A simple algorithm locates beta-strands in the amyloid fibril core of alpha-synuclein, Abeta, and tau using the amino acid sequence alone (Q42276744) (← links)
• Oligomerization of the microtubule-associated protein tau is mediated by its N-terminal sequences: implications for normal and pathological tau action (Q42575598) (← links)
• Thermodynamic analysis of the aggregation propensity of oxidized Alzheimer's beta-amyloid variants. (Q43057789) (← links)
• Mutagenic analysis of the nucleation propensity of oxidized Alzheimer's beta-amyloid peptide (Q43093895) (← links)
• Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study (Q43240569) (← links)
• Oxidation of methionine 35 attenuates formation of amyloid beta -peptide 1-40 oligomers (Q43931371) (← links)
• Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide (Q44007142) (← links)
• Methionine oxidation inhibits fibrillation of human alpha-synuclein in vitro (Q44026039) (← links)
• Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease (Q44116115) (← links)
• Amyloid aggregates of the prion peptide PrP106-126 are destabilised by oxidation and by the action of dendrimers (Q45140134) (← links)
• Effect of methionine-35 oxidation on the aggregation of amyloid-β peptide (Q45568413) (← links)
• Surprising toxicity and assembly behaviour of amyloid β-protein oxidized to sulfone. (Q45991189) (← links)
• An Iridium(III) Complex as a Photoactivatable Tool for Oxidation of Amyloidogenic Peptides with Subsequent Modulation of Peptide Aggregation. (Q46457857) (← links)
• pH effects on the conformational preferences of amyloid beta-peptide (1-40) in HFIP aqueous solution by NMR spectroscopy. (Q46785592) (← links)
• Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution (Q48248811) (← links)
• Copper-dependent inhibition of cytochrome c oxidase by Abeta(1-42) requires reduced methionine at residue 35 of the Abeta peptide (Q48417401) (← links)
• Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress (Q50516147) (← links)
• Interaction between beta-amyloid and lens alphaB-crystallin. (Q53238752) (← links)
• Molecular dynamics studies of α-helix stability in fibril-forming peptides (Q58327982) (← links)
• Methionine Oxidation Changes the Mechanism of Aβ Peptide Binding to the DMPC Bilayer (Q64057222) (← links)
• Ion mobility spectrometry combined with multivariate statistical analysis: revealing the effects of a drug candidate for Alzheimer's disease on Aβ1-40 peptide early assembly (Q92583454) (← links)